Crowdonomics
Pharmagreen Biotech Inc.

Reg A+ · Equity · Apr 2021

ClosedReg A+Equity
via DALMORE GROUP LLC · last checked Aug 16, 2026
Raised
$0 / $9M max
0% of ceiling
Investors
—
—
Estimated pre-money
$10.4M
—

Financials disclosed in this offering

FY2020 · hover for source
$0
−$2.4M
FY2020
RevenueNet income
Metric
FY2020 audited
Income statement
Revenue
$0
Cost of goods sold
$3,769,058
Net income
-$2,437,870
Taxes paid
$0
Balance sheet
Cash
$12,196
Accounts receivable
$0
Total assets
$266,245
Long-term debt
$30,028
Total liabilities
$3,200,350
Other
Headcount
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Aug 30, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Jul 16, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Jun 22, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$10.4M
Price / share$0.03
Shares offered300,000,000

Estimated, not stated: $0.03 × 348,018,019 securities outstanding.

Offering details

Target—
Max$9,000,000
Min investment—
OpenedApr 14, 2021
Deadline—
Days active2,004

Links & provenance

Source: SEC EDGAR
0001273511-21-000133
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.